Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

A deeper understanding of the inflammatory processes driving psoriasis and psoriatic arthritis is translating ... immune pathways involved in psoriasis pathogenesis 9. “We now have a lot of ...

Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

There are dozens of medications available with or without a prescription to treat the various forms of arthritis. Your doctor can help you choose what drugs are best for your particular disease.

The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to studies reported here. More than half of patients with psoriatic arthritis ...